Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1995
Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in ratsA Gobert, F Lejeune, J M Rivet, et al.
Neuroscience|April 16, 1998
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of releaseA Gobert, J M Rivet, V Audinot, et al.
Brain Research|March 17, 1987
Catecholamines and conditioned blocking: effects of ventral tegmental, septal and frontal 6-hydroxydopamine lesions in ratsR D Oades, J M Rivet, K Taghzouti, et al.
Immunology Letters|July 1, 1988
Brain norepinephrine levels after BCG stimulation of the immune systemP Barneoud, J M Rivet, S Vitiello, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2003
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924A Newman-Tancredi, J-M Rivet, D Cussac, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Multiple alpha-2 adrenergic receptor subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors in the control of nociception, motor behavior and hippocampal synthesis of noradrenalineM J Millan, K Bervoets, J M Rivet, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 17, 2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramineM J Millan, A Gobert, F Lejeune, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1995
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathwaysA Gobert, J M Rivet, V Audinot, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1997
S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activityM J Millan, A Newman-Tancredi, J M Rivet, et al.
Brain Research|November 22, 2001
Dopamine D2 receptor-mediated G-protein activation in rat striatum: functional autoradiography and influence of unilateral 6-hydroxydopamine lesions of the substantia nigraA Newman-Tancredi, D Cussac, M Brocco, et al.
Pageof 6